Last updated on April 2012

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares in Patients Unable to Use NSAIDs and/or Colchicine.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Acute Gout
  • Age: Between 18 - 85 Years
  • Gender: Male or Female
  • Other:
    Patients who have either:
    Completed the first extension study CACZ885H2357E1 or
    Experienced a ninth new flare within the core study CACZ885H2357 and the first
    extension study CACZ885H2357E1

You may not be eligible for this study if the following are true:

  • Continuation in this extension study is considered inappropriate by the treating
    Pregnant or nursing (lactating) women
    Female patients being physiologically capable of becoming pregnant UNLESS they are
    using an acceptable method of contraception with a failure rate (Pearl Index (PI)) <
    1 Other protocol defined inclusion/exclusion criteria may apply.

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.